| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |